|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Proposal for classifying the acute emetogenicity of cancer chemotherapy 显示文摘 | Hesketh PJ Kris MG Grunberg SM | 1997 | Clin Oncol1997，15，1： | 1 |
| 2 | Control of chemotherapy - induced emesis显示文摘 | Grunberg SM Hesketh PJ | 1993 | N Engl J Med1993，329，24： | 1 |
| 3 | The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational,randomized,double-blind, placebo-controlled trial in patients receiving high-dose cisplatin-- the Aprepitant Protocol 052 Study Group 显示文摘 | Hesketh PJ Grunberg SM Gralla RJ | 2003 | J Clin Oncol2003，21，22： | 1 |
| 4 | The oral NK 1 antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting- Pooled data from 2 randomised, double-blind, placebo controlled trials显示文摘 | Warr DG Grunberg SM Gralla RJ | 2005 | EurJ Cancer2005，41，9： | 1 |
| 5 | Incidence of Chemotherapy - induced nausea and emesis after modern Anti - emetics 显示文摘 | Grunberg SM Deuson RR Mavros P | 2004 | Cancer2004，100，10： | 1 |
| 6 | Antiemetic activity of corti- costeroids in patients receiving cancer chemotherapy: dosing, efficacy, and tolera- bility analysia 显示文摘 | Grunberg SM | 2007 | Ann oncol2007，18，2： | 1 |
| 7 | The Oral Neurokinin-1 Antagonist Aprepitam for the Prevention of Chemotherapy-Induced Nausea and Vomiting:A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin-The Aprepitant Protocol 052 Study Group显示文摘 | Hesketh P J Grunberg SM Gralla RJ | 2003 | J Clin Oncol2003，21，： | 1 |
| 8 | A phase III, double-blind, randomized trial of palonosetron compared with on- dansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy显示文摘 | Aapro MS Grunberg SM Manikhas GM | 2006 | Ann On- col2006，17，9： | 1 |
| 9 | The oral neurokinin- 1 antagonist aprepitant for the prevention of chemotherapy-inducednausea and vomiting : a multinational, randomized, double-blind, placebo-controlled trim in patients receiving high-dose cisplatin-- the Aprepitant Protocol 052 Study Group 显示文摘 | Hesketh P J Grunberg SM Gralla R J | 2003 | J Clin Oncol2003，21，22： | 1 |
| 10 | Incidence of chemotherapy-induced nausea and emesis after modern antiemetics显示文摘 | Grunberg SM Deuson RR Mavros P | 2004 | Cancer2004，100，10： | 1 |
| 11 | Control of chemotherapy-induced emesis显示文摘 | Grunberg SM Hesketh PJ | 1993 | N Engl J Med1993，329，24： | 1 |
| 12 | Management of patients receiving long-term treatment with mifepristone显示文摘 | Spitz IM Grunberg SM Chabbert-Buffet N | 2005 | Fertil Steril2005，84，： | 1 |
| 13 | The oral NK (1) antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting: Pooled data from 2 randomised, double-blind, placebo controlled trials显示文摘 | Warr DG Grunberg SM Gralla R J | 2005 | Eur J Cancer2005，41，9： | 1 |
| 14 | Progressive paresthesias after cessation of therapy with very high-dose cisplatin显示文摘 | Grunberg SM Sonka S Stevenson LL | 1989 | Cancer Chemother Pharmacol1989，25，1： | 1 |
| 15 | Incidence of chemotherapy-induced nausea and emesis after modern antiemetics显示文摘 | GRUNBERG SM DEUSON RR MAVROS P | 2004 | Cancer2004，100，10： | 1 |
| 16 | Proposal for classifying the acute emetogenicity of cancer chemotherapy显示文摘 | Hesketh PJ Kris MG Grunberg SM | 1997 | J Clin Oncol1997，15，： | 1 |
| 17 | Incidence of chemotherapy-induced nausea and emesis after modern antiemetics显示文摘 | Grunberg SM Deuson RR Mavros P | 2004 | Cancer2004，100，： | 1 |
| 18 | A phase III, double- blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy显示文摘 | Aapro MS Grunberg SM Manikhas GM | 2006 | Ann Oncol2006，17，9： | 1 |
| 19 | A phase Ⅲ,doubleblind,randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy显示文摘 | Aapro MS Grunberg SM Manikhas GM | 2006 | Ann Oncol2006，17，9： | 1 |
| 20 | A phase Ⅲ,double-blind,randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy显示文摘 | Aapro MS Grunberg SM Manikhas GM | 2006 | Ann Oncol2006，17，9： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员